ROSEN, A LEADING LAW FIRM, Encourages Investors in Orthofix Medical Inc. to Retain Counsel Ahead of Key Deadline in Securities Class Action – OFIX

New York, New York–(Newsfile Corp. – September 16, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Orthofix Medical Inc. (NASDAQ: OFIX) common stock between October 11, 2022 and September 12, 2023, both dates inclusive (the “Class Period”), of the important Deadline for lead plaintiffs: October 21, 2024.

SO WHAT: If you purchased Orthofix common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a no win, no fee arrangement.